Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Paul Liknaitzky"'
Publikováno v:
Psychoactives, Vol 3, Iss 2, Pp 137-166 (2024)
A set of interventions that can produce altered states of consciousness (ASC) have shown utility in the treatment of substance misuse. In this review, we examine addiction-related outcomes associated with three common interventions that produce ASCs:
Externí odkaz:
https://doaj.org/article/5b31da4b143b44f1a06117efbcb9f64e
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
As investigations into the efficacy of psychedelic-assisted psychotherapy to treat depression continue, there is a need to study the possible mechanisms of action that may contribute to the treatment’s antidepressant effects. Through a two-round De
Externí odkaz:
https://doaj.org/article/0453cf8d90824063832325e935a49baf
Autor:
Jonathan Brett, Elizabeth Knock, P. Todd Korthuis, Paul Liknaitzky, Kevin S. Murnane, Christopher R. Nicholas, James C. Patterson, Christopher S. Stauffer
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
Methamphetamine use disorder is a chronic relapsing condition associated with substantial mental, physical, and social harms and increasing rates of mortality. Contingency management and psychotherapy interventions are the mainstays of treatment but
Externí odkaz:
https://doaj.org/article/32d58082fc734733bcbddda1eb05009b
Publikováno v:
Systematic Reviews, Vol 11, Iss 1, Pp 1-9 (2022)
Abstract Background There is currently renewed interest in the use of psychedelic therapy in the treatment of psychiatric disorders, including depression. The proposed systematic review will aim to identify, evaluate and summarise the psychological p
Externí odkaz:
https://doaj.org/article/37309a7b86cc4a22871c85597ab80fa4
Autor:
Martin L. Williams, Diana Korevaar, Renee Harvey, Paul B. Fitzgerald, Paul Liknaitzky, Sean O'Carroll, Prashanth Puspanathan, Margaret Ross, Nigel Strauss, James Bennett-Levy
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Research exploring the potential of psychedelic-assisted therapies to treat a range of mental illnesses is flourishing, after the problematic sociopolitical history of psychedelics led to the shutdown of clinical research for almost 40 years. Encoura
Externí odkaz:
https://doaj.org/article/8ebc93b13d294a1a9d79debad29b087f
Publikováno v:
Frontiers in Neuroscience, Vol 14 (2020)
Anorexia nervosa (AN) has the highest mortality rate of any psychiatric disease, yet available pharmacological treatments are largely ineffective due, in part, to an inadequate understanding of the neurobiological drivers that underpin the condition.
Externí odkaz:
https://doaj.org/article/39f089582bd34327ae48f1cda8c1e622
Autor:
Petra Karin Staiger, Paul Liknaitzky
Publikováno v:
Clinical Psychologist. 25:124-130
Autor:
Jerome Sarris, Dan Siskind, Paul Liknaitzky, Nicole Leite Galvão-Coelho, Daniel Hoyer, Martin Williams, Greg Murray, David G Penington, Yvonne Bonomo, David Forbes, Sean Hood, Susan L. Rossell, Christopher G. Davey, Michael Berk, Olivia Carter, Violeta Schubert, David J. Castle, Daniel Perkins, Meaghen O'Donnell, Colleen Loo
Publikováno v:
Australian & New Zealand Journal of Psychiatry. 55:1127-1133
The medical use of psychedelic substances (e.g. psilocybin, ayahuasca, lysergic acid diethylamide and 3,4-methylenedioxymethamphetamine) is attracting renewed interest, driven by a pressing need for research and development of novel therapies for psy
Publikováno v:
ACS Pharmacol Transl Sci
[Image: see text] Psychedelic and mindfulness interventions have been shown to improve mental ill-health and wellbeing, with a range of clinical processes and effects in common. However, each appear to contain specific challenges in the context of me